Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Ambrisentan“
Suchtreffer
Begriffe & Kennungen
Ambrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Peripheral oedema (37%) and headache (28%) were the most common adverse reactions observed with ambrisentan. T
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Reductions in haemoglobin concentrations and haematocrit (10%) have been associated with ERAs including ambris
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Serious adverse reactions associated with ambrisentan use include anaemia (decreased haemoglobin, decreased ha
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Summary of the safety profile
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · System organ class Frequency Adverse reaction(s) Blood and lymphatic system Very common Anaemia (decreased hae
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenVolibris · 4.5 · 6 when co-administered with cyclosporine A, the dose of ambrisentan in adult patients or paediatric patients w
Eintrag öffnenVolibris · 4.5 · Ambrisentan does not inhibit or induce phase I or II drug metabolising enzymes at clinically relevant concentr
Eintrag öffnenVolibris · 4.5 · Ambrisentan had no effects on the steady-state pharmacokinetics and anti-coagulant activity of warfarin in a h
Eintrag öffnenVolibris · 4.5 · Ambrisentan is a substrate for Pgp-mediated efflux.
Eintrag öffnenVolibris · 4.5 · Co-administration of ambrisentan with a phosphodiesterase inhibitor, either sildenafil or tadalafil (both subs
Eintrag öffnenVolibris · 4.5 · Effect of ambrisentan on xenobiotic transporters
Eintrag öffnenVolibris · 4.5 · In a clinical study in healthy volunteers, steady-state dosing with ambrisentan 10 mg once daily did not signi
Eintrag öffnenVolibris · 4.5 · In vitro studies in rat hepatocytes also showed that ambrisentan did not induce Pgp, BSEP or MRP2 protein expr
Eintrag öffnenVolibris · 4.5 · In vitro, ambrisentan has no inhibitory effect on human transporters at clinically relevant concentrations, in
Eintrag öffnenVolibris · 4.5 · Steady-state administration of ambrisentan in healthy volunteers had no clinically relevant effects on the sin
Eintrag öffnenVolibris · 4.5 · Steady-state co-administration of ambrisentan and cyclosporine A resulted in a 2-fold increase in ambrisentan
Eintrag öffnenVolibris · 4.5 · The efficacy and safety of ambrisentan when co-administered with other treatments for PAH (e.g. prostanoids an
Eintrag öffnen